We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Smoking a Risk Factor for Macular Degeneration

By HospiMedica staff writers
Posted on 09 Apr 2001
A study pooling the results from several eye-disease studies conducted on three continents shows that tobacco smoking is the principal known preventable risk factor for age-related macular degeneration (AMD). More...
The study was published in the April issue of Ophthalmology, the clinical journal of the American Academy of Ophthalmology.

Based on data collected from Australia, the Netherlands, and the United States, the study concluded that apart from age, tobacco smoking is the only risk factor consistently associated with any form of AMD in each location and overall. There is no known cure for dry AMD. Laser photocoagulation and photodynamic therapy can stabilize wet AMD if treatment is started early.

Although the study showed the prevalence of wet AMD to be twice that of dry AMD, this ratio was smaller in the Netherlands study. The researchers suggest that the explanation may be due to important genetic differences and gene-environment interactions among the three communities. They call for more research to identify genes that may predispose people to develop AMD.

"This study corroborates and reinforces previous studies that have suggested the link between tobacco smoking and the development of macular degeneration. The Academy supports the author's call for increased health advocacy efforts to reduce the smoking rate, including among the elderly,” said Paul Sternberg, Jr., M.D., AAO spokesperson.




Related Links:
American Academy of Ophthalmology

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.